Get Our FREE Newsletter

Sign Up

Bicycle Therapeutics Prices $175 Mln ADS

Spread the love

(RTTNews) – U.K.-based Bicycle Therapeutics plc (BCYC), a biotechnology company pioneering proprietary bicyclic peptide technology-based therapeutics, on Wednesday announced $54 as the price per American Depositary Shares (ADS) of its underwritten and upsized public offering of 3

This post was originally published on this site